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Peroxidases are enzymes that reduce hydroperoxide substrates. Inmany cases, hydroperoxide reduction is coupled to the formation
of a disulfide bond, which is transferred onto specific acceptor molecules, the so-called reducing substrates. As such, peroxidases
control the spatiotemporal distribution of diffusible second messengers such as hydrogen peroxide (H
2
O
2
) and generate new
disulfides. Members of two families of peroxidases, peroxiredoxins (Prxs) and glutathione peroxidases (GPxs), reside in different
subcellular compartments or are secreted from cells.This review discusses the properties and physiological roles of PrxIV,GPx7, and
GPx8 in the endoplasmic reticulum (ER) of higher eukaryotic cells where H
2
O
2
and—possibly—lipid hydroperoxides are regularly
produced. Different peroxide sources and reducing substrates for ER peroxidases are critically evaluated. Peroxidase-catalyzed
detoxification of hydroperoxides coupled to the productive use of disulfides, for instance, in the ER-associated process of oxidative
protein folding, appears to emerge as a common theme. Nonetheless, in vitro and in vivo studies have demonstrated that individual
peroxidases serve specific, nonoverlapping roles in ER physiology.
1. Introduction
Hydrogen peroxide (H
2
O
2
) is an intracellular metabolite,
which serves important roles as a second messenger in
redox signaling [1]. However, since elevated levels of H
2
O
2
(and of other reactive oxygen species, ROS) can damage
proteins, nucleic acids, and lipids by peroxidation, temporal
and spatial limitation of H
2
O
2
levels is critically important.
Thus, half-life and spatial distribution of H
2
O
2
in the cell
are tightly regulated by nonenzymatic antioxidants as well
as by specific scavenging enzymes, including the so-called
peroxidases of the peroxiredoxin (Prx) or glutathione per-
oxidase (GPx) families [2]. Prx and GPx isoforms reside in
different subcellular compartments where they catalyze the
reduction of H
2
O
2
to H
2
O [2]. The most relevant producers
of intracellular ROS/H
2
O
2
are the transmembrane enzyme
complexes of the nicotinamide adenine dinucleotide oxidase
(NOX) family, various enzymes and the respiratory chain in
mitochondria, peroxisomal enzymes, and sulfhydryl oxidases
in the endoplasmic reticulum (ER) [3–7]. Due to the presence
of specific aquaporin channels in cellular membranes, the
local diffusion of H
2
O
2
is usually not restricted by organelle
boundaries [8, 9].
There are a total of six isoforms of Prx in mammals, all
of which form distinct types of antiparallel homooligomers
[10]. H
2
O
2
-mediated oxidation of the active site peroxidatic
cysteine (CP) to a cysteine sulfenic acid is a common
feature of Prxs. However, only so-called 2-Cys Prxs possess
a resolving cysteine (CR), which attacks the CP sulfenic acid,
leading to the formation of a CR–CP disulfide bond. In typical
2-Cys Prxs, the CR–CP disulfide connects antiparallel dimers,
whereas in atypical 2-Cys Prxs, it forms intramolecularly. In
order to complete the catalytic cycle, these disulfide bonds
are reduced by a thioredoxin-type oxidoreductase [10–12].
In contrast, 1-Cys Prxs (such as human PrxVI) lack a CR
and instead form a mixed disulfide heterodimer with 𝜋
glutathione S-transferase, which catalyzes the glutathione-
driven reductive regeneration of the Prx [13, 14].
A remarkable feature of Prxs is their susceptibility to
oxidative inactivation. Thus, CP sulfenic acid can react with
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a second molecule of H
2
O
2
, which gives rise to CP sulfinic
acid.This leads to Prx inactivation, stabilization of decameric
over dimeric configuration, and, in some cases, to an increase
in chaperone activity [15–17]. At least in cytoplasmic and
mitochondrial typical 2-Cys Prxs, sulfinic acid formation can
be reversed by the action of sulfiredoxin at the expense of
ATP [18, 19]. Under highly oxidizing conditions, CP sulfinic
acid can further and irreversibly react with a third molecule
of H
2
O
2
to form CP sulfonic acid [15].
The GPx family is phylogenetically unrelated to Prxs
but shares the ability to reduce hydroperoxide substrates
[2]. A total of eight mammalian GPxs are known. They are
subclassified into two groups according to the amino acid
tetrad in their catalytic center. In SecGPxs (human GPx1–4
and 6) or CysGPxs (GPx5, 7, and 8), the common constituents
Gln, Trp, and Asn are supplemented with a peroxidatic
selenocysteine (Sec) or Cys, respectively [20]. Furthermore,
GPxs differ with regard to their oligomeric state, with GPx1–
3, 5, and 6 constituting homotetramers and GPx4, 7, and 8
monomers [21].
Upon hydroperoxide-mediated oxidation of the active-
site selenocysteine, SecGPxs typically react with two
molecules of glutathione (GSH) yielding glutathione
disulfide (GSSG), which historically accounted for the
generalized family name glutathione peroxidases [2, 21].
However, the use of GSH as reductant is not a common
feature of GPxs nor is it strictly conserved within the SecGPx
subgroup [2, 21–25]. In invertebrates and plants, monomeric
CysGPxs harbor a CR and exhibit an identical reaction
mechanism as atypical 2-Cys Prxs (see above) [20, 26, 27]. In
contrast, no typical CR is present in the human monomeric
CysGPxs GPx7 and 8.
The ER serves many distinct cellular functions [28]. One
of these is chaperone-mediated folding of nascent polypep-
tide chains, which often involves the introduction of disulfide
bonds via oxidation of two adjacent cysteines. This process
termed oxidative protein folding is driven by a number of
distinct pathways, the most conserved of which involves the
sulfhydryl oxidase endoplasmic oxidoreductin 1 (Ero1) as
disulfide donor [29]. Since Ero1 can utilize molecular oxygen
(O
2
) as terminal electron acceptor, it generates stoichiomet-
ric amounts of H
2
O
2
for every disulfide bond produced,
as demonstrated in vitro [30]. In addition, H
2
O
2
sources
other than the paralogs Ero1𝛼 and Ero1𝛽 exist within the
mammalian ER. Although initially assigned to phagocytic
cells only, more recent findings have shown that NOX family
members are expressed in various cell types [3] where
they produce H
2
O
2
at different subcellular sites including
the ER [31–33]. Likewise, the secreted quiescinsulfhydryl
oxidases were identified as producers of H
2
O
2
[34], although
these enzymes function in the extracellular space [35] and
their contribution to intracellular oxidative protein folding
is uncertain [36, 37]. It has also been suggested that ROS
produced by mitochondrial respiration could impact on
disulfide-bond formation in secretory compartments includ-
ing the ER [38]. Leakage of the mitochondrial electron trans-
port chain, predominantly at complex III, releases superoxide
andH
2
O
2
into the intermembrane space ofmitochondria [39,
40]. The close apposition of ER and mitochondria [41] could
enable these ROS to contribute to ER-associated oxidative
protein folding.
This review will focus on PrxIV, GPx7, and GPx8, which
reside in the ER of vertebrates, lancelets, ascidians, and—
in case of PrxIV—echinoderms and arthropods [42]. As
detailed further below, all ER-resident peroxidases can use
protein disulfide isomerases (PDIs; the “thioredoxins of the
ER”) as reducing substrates, allowing them to exploit the
oxidizing power of ER peroxide sources for oxidative protein
folding. However, reducing substrates other than PDIs may
also participate in the reaction cycle of ER peroxidases.
2. H2O2 in the ER: Bulk Metabolite or
Locally Restricted Messenger?
Reliable detection of the cellular distribution of H
2
O
2
is
a challenging task. The recent development of genetically
encoded sensors, which can be expressed in different subcel-
lular compartments, significantly facilitated the monitoring
of spatial and temporal changes in H
2
O
2
/ROS concentration
[43]. For instance, targeted expression of the yellow fluores-
cent protein-based, ratiometric, and H
2
O
2
-sensitive HyPer
sensor was used to record the oxidizing environment in the
mammalian ER [33, 44–46]. On the basis of the predomi-
nantly oxidized state of ER-localized HyPer (HyPerER) and
the predominantly reduced state of HyPer on the cytoplasmic
surface of the ER, a high [H
2
O
2
]ER, which is strictly confined
to the lumen of the organelle, has been inferred [44]. Several
lines of evidence argue against this interpretation though.
First, as detailed in the following paragraph, numerous
examples for signaling roles of ER-derived H
2
O
2
are known,
which suggest analogy to the critical involvement of Nox-
derived H
2
O
2
in receptor tyrosine kinase (RTK) signal
transduction at the cell surface [47–50] (Figure 1). Second, the
presence of peroxidases in the ER lumen (see below) appears
incompatible with a high steady-state [H
2
O
2
]ER. Third, the
demonstration of aquaporin 8-facilitated entry of H
2
O
2
into
the ER [8] suggests that aquaporin 8 can also facilitate exit
of ER-derived H
2
O
2
(see also Figure 1). Forth, since the
ratiometric readout of HyPer is based on the formation of
an intramolecular disulfide bond [51], oxidation of HyPer
in the ER could be catalyzed by resident oxidoreductases
independently of H
2
O
2
. Consistent with this assumption, no
effect on HyPerER oxidation was observed upon overexpres-
sion of PrxIV or of ER-targeted catalase in pancreatic beta-
cells [46]. The increased oxidation of HyPerER observed in
response to higher levels of Ero1𝛼 [44, 52] can therefore reflect
both enhanced oxidation of PDIs and a rise in [H
2
O
2
]ER.
Thus, the Ero1𝛼-induced increase in oxidation ofHyPerER can
only be partially reversed by addition of the H
2
O
2
scavenger
butylated hydroxyanisole (our unpublished observations).
Conversely, increased oxidation of HyPerER in response to
NOX4 induction is blunted by coexpression of catalase in the
ER [33].
The role ofH
2
O
2
as signalingmolecule typicallymanifests
in the formation of short-lived microdomains of elevated
[H
2
O
2
] [49, 53]. For instance, ligand binding to RTKs at the
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Figure 1: RTK signaling involves NOX-derivedH
2
O
2
as secondmessenger. (a) Binding of ligand (L) to receptor tyrosine kinases (RTK) on the
cell surface activates NADPH oxidases (NOX) and leads to the generation of extracellular or, following endocytosis, endosomal superoxide
(O
2
−), which can be dismutated to H
2
O
2
(black filled circles). Upon aquaporin 8 (AQP8)-facilitated diffusion across the plasma/endosomal
membrane, H
2
O
2
locally inactivates the intracellular negative regulators phosphotyrosine phosphatases (PTPs) and peroxiredoxins (Prxs),
which prolongs RTK signal transduction.This stepmostly, but not exclusively (as depicted by an asterisk), involves the endoplasmic reticulum
(ER)-associated PTP1B. Spatial restriction of H
2
O
2
is achieved by cytosolic ROS scavengers like Prxs. (b) An ER-centered route of RTK-
mediated signal transduction involves NOX4 in the ER membrane and PTP1B. In this context, ER-luminal buildup of H
2
O
2
is controlled by
ER-resident PrxIV.
cell surface such as platelet-derived growth factor receptor,
epidermal growth factor receptor (EGFR), or insulin receptor
stimulates the local production of H
2
O
2
via crosstalk with
NOX enzymes [47, 49, 54, 55]. This leads to oxidative
inactivation of protein tyrosine phosphatases (PTPs), which
prolongs RTK signaling until cytosolic ROS scavengers such
as Prxs have cleared H
2
O
2
[56–60] (Figure 1(a)). At least
in certain contexts, such H
2
O
2
-dependent signal amplifi-
cation is mediated by ER-resident NOX4 and PTP1B [31]
(Figure 1(b)). Thus, activated EGFR is internalized into
endosomes and transported close to the ER [61] where its
PTP1B-dependent dephosphorylation is negatively regulated
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by NOX4-derived H
2
O
2
[31]. In the case of the granulocyte-
colony stimulating factor receptor pathway, also ER-resident
PrxIV (see next section) can modulate the signaling ampli-
tude [62] (Figure 1(b)).
NOX4-initiated signal transduction is linked to the
adaptive/apoptotic output of the ER stress response—a con-
glomeration of ER-derived signaling cascades known as
the unfolded protein response (UPR) [63]. In the context
of atherosclerosis, oxysterol-stimulated smooth muscle cell
apoptosis depends on NOX4, which is upregulated through
the ER stress sensor Ire1𝛼 to produce H
2
O
2
[32]. Similarly,
NOX4 is induced in endothelial cells in response to a subset
of ER stressors, leading to presumably locally restricted
H
2
O
2
signaling [33]. In both cases, proper activation of UPR
pathways requires NOX4-derived H
2
O
2
. Of note, NOX4-
dependent, ER-associated oxidative signaling through the
RAS-ERK pathway in endothelial cells promotes prosurvival
autophagy rather than cell death [33]. A related link operates
in smooth muscle cells where NOX4-derived H
2
O
2
stim-
ulates autophagy by inhibiting autophagy-related gene 4B
activity, which antagonizes ER stress and cell death [64].
Little is known about signaling roles of H
2
O
2
sources
other than NOX4 in the ER. Nevertheless, the available data
onNOX4 strongly suggest that—in analogy to the situation in
other compartments—H
2
O
2
operates in the ER as a spatially
restricted second messenger rather than a bulk metabolite.
3. Peroxiredoxin IV
PrxIV is the only ER-resident representative of the Prx family.
Its predominant isoform harbors a classical signal peptide,
which is cleaved upon cotranslational entry into the ER, but
no ER retrieval motif to ensure its retention in the early
secretory pathway (ESP) [65, 66]. Instead, similar to the ER
retention mechanism of Ero1𝛼, physical interactions with the
ESP oxidoreductases ERp44 and PDI inhibit PrxIV secretion
from cells [67]. Therefore, cell-specific differences and/or
saturation of the retrieval machinery, for example, following
exogenous overexpression, might explain the ambiguity in
the literature on the intracellular or secreted nature of PrxIV
[68–72]. This review will focus on the role of the ER-resident
fraction of PrxIV.
PrxIV belongs to the subclass of typical 2-Cys Prxs
and predominantly exists in decameric configuration. The
toroid shaped pentamer of antiparallel dimers (Figure 2)
is stabilized by hydrophobic interactions at dimer-dimer
interfaces. In contrast to other family members [73], PrxIV
does not show significant transition from the decameric to
the dimeric state upon disulfide-bond formation between
CP and CR, even though this process is associated with
local unfolding [74]. Furthermore, PrxIV harbors a unique
N-terminal extension. As judged from the positions of the
truncated N-termini in the crystal structure, these flexible
extensions protrude into the center of the decameric assembly
of full length PrxIV protomers (Figure 2). In addition to
hydrophobic interactions, neighboring antiparallel dimers
are linked byCys51–Cys51 interchain disulfide bonds between
N-terminal regions (Figure 2), but mutagenesis to serine
N
TR NT
R
C124
C51C51
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C245
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Figure 2: Oligomeric structure of PrxIV. (a) Upon peroxide-
mediated oxidation, antiparallel PrxIV dimers are transiently linked
by disulfide bonds between CP (C
124) on one subunit and CR (C
245)
on the other subunit (depicted in red), which is the characteristic
feature of typical 2-Cys Prxs. However, dimer formation relies
on hydrophobic interactions and is redox state-independent. The
flexible N-terminal region (NTR) of PrxIV is oriented towards the
center of the toroid-shaped, decameric complex (b). The role of
the disulfide bonds linking adjacent dimers via Cys51 in the NTR
(depicted in blue) is currently unclear.
or alanine neither affected decamerization nor the catalytic
parameters of PrxIV [74–76]. The impact of the N-terminal
extensions for correct quaternary structure is still unclear.
In an N-terminal truncation mutant, Wang et al. observed a
significant transition from the decameric to the dimeric state
upon oxidation. In contrast to this, Ikeda et al. reported a shift
from decameric to higher oligomeric forms [76, 77].
Like other Prxs, PrxIV exhibits an exceptionally fast
reactivity towards H
2
O
2
(2.2 × 107M−1 s−1) [76]. As data on
PrxIV reacting with peroxide substrates other than H
2
O
2
is scarce, PrxIV may exclusively react with H
2
O
2
in vivo
(Table 1). PrxIV knockout cells stained with H
2
O
2
-reactive
dye showed a bright signal, which was blunted upon recon-
stitution of PrxIV (Figure S(10) in [62]). Where does this
H
2
O
2
come from?Apopularmodel implicates Ero1𝛼-derived
H
2
O
2
, a regular byproduct of oxidative protein folding [78],
as oxidizing substrate of PrxIV [79]. This model is based
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on the finding that activation of Ero1𝛼 in cells by dithio-
threitol (DTT)-mediated reduction of its regulatory disulfide
bonds increased the hyperoxidized fraction of PrxIV [80].
In further support, DTT-triggered hyperoxidation of PrxIV
was inhibited by knockdown of Ero1𝛼 (Neil Bulleid, per-
sonal communication), and Ero1𝛼-dependent accumulation
of H
2
O
2
in response to DTT treatment was increased by
PrxIV knockdown and decreased by PrxIV overexpression
(our unpublished observations). However, in contrast to
GPx8 (see below), this crosstalk between Ero1𝛼-derived
H
2
O
2
and PrxIV was only observed in the presence of DTT
(our unpublished observations), which likely does not reflect
normal physiology. Experiments with murine or fungal loss-
of-function models of Ero1 strongly suggested that PrxIV
can be coupled to (an) Ero1-independent source(s) of H
2
O
2
:
ectopic expression of PrxIV rescues the thermosensitive ero1-
1 yeast strain by Ero1-independent oxidative protein folding
[81] (see below) and PrxIV is required to protect Ero1-
deficient mice against H
2
O
2
-mediated ascorbate depletion
[82]. The H
2
O
2
source(s) targeted by PrxIV remain(s) to be
identified [12].
Following disulfide-bond formation between CP and CR,
PrxIV acts as PDI peroxidase by using several different PDIs
as electron donors [75, 83] (Table 1). As discussed further
below, these PDIs can subsequently shuttle the disulfide onto
various substrate proteins, implicating PrxIV as an important
element of oxidative protein folding.
It is intriguing that despite the fact that the ER is devoid
of sulfiredoxin activity, PrxIV has retained specific structural
features to support H
2
O
2
-mediated hyperoxidation [74, 76].
Accordingly, sulfinylation of CP in PrxIV could potentially
serve a specific function. It has been speculated that hyper-
oxidized PrxIV could operate as a molecular chaperone or as
a secreted damage associated molecular pattern [65].
4. GPx7 and GPx8
GPx7 and 8 are closely related ER-luminal members of the
GPx family. Whereas GPx7 possesses a cleavable N-terminal
signal sequence, GPx8 is a transmembrane protein with a
short N-terminal cytoplasmic tail. Retention in the ESP is
mediated by exposed, C-terminal motifs, -Arg-Glu-Asp-Leu
and-Lys-Glu-Asp-Leu in GPx7 and 8, respectively, which are
recognized in the Golgi by KDEL retrieval receptors [84].
This ESP-retentionmechanism is noteworthy for GPx8, since
ER membrane proteins are usually retrieved to the ER via
cytosolic interactions with retrograde coat proteins [85]. The
physiological implications of this peculiarity are currently
unclear.
Whereas no other peroxide substrate besides H
2
O
2
has
been documented for GPx8 yet, GPx7 (also known as
nonselenocysteine containing phospholipid hydroperoxide
glutathione peroxidase, NPGPx) can efficiently react with
phospholipid hydroperoxides in vitro (𝑘 > 103M−1 s−1,
Table 1) [86]. Although speculative at present, we consider
it possible that also in its native context, GPx7 can reduce
lipid peroxidation products in the luminal leaflet of the ER
membrane. As to GPx8, which largely shares the active site
TMD (GPx8)
KEDL motif (GPx8)
GPx8
GPx7
CP (active site)
Figure 3: Superimposition of GPx7 and GPx8. Overlay of the
carbon-nitrogen backbones ofGPx7 (green; PDB ID2KIJ) andGPx8
(red; PDB ID 2P31) was done using the Swiss PDB viewer software
(available at http://www.expasy.org/). The close resemblance of the
two three-dimensional structures is particularly appreciable in the
peptide loops surrounding the active site Cys (CP). The ESP reten-
tion signal (KEDL motif) and the location of the transmembrane
domain (TMD) of GPx8 (not part of the crystal structure) are
indicated.
architecture with GPx7 (Figure 3), the short linker between
the transmembrane anchor and the catalytic domain might
not confer enough flexibility for the active site to interact
with the lipid bilayer. Accordingly, both GPxs (together with
PrxIV) could protect ER-oriented lipids against peroxidation
by scavenging ER-luminal H
2
O
2
, but only soluble GPx7, in
analogy to GPx4 [87], would be able to directly reverse lipid
peroxidation by enzymatic reduction.
Another prevailing model implicates Ero1 activity to
provide H
2
O
2
as oxidizing substrate for GPx7 and 8 [21, 88].
Using a split YFP complementation approach, Ero1𝛼 and
GPx7 or 8were found to associatewithin the ER, and addition
of GPx7 increased the oxidase activity of Ero1𝛼 in vitro [88].
While the mechanistic basis for the latter finding remains
to be elucidated, these data point to a functional interaction
between GPxs and Ero1𝛼. In line with this, knockdown
of GPx8 but not PrxIV aggravated the accumulation of
H
2
O
2
induced by a deregulated Ero1𝛼 mutant (our unpub-
lished observations). Therefore, despite their lower reactivity
towards peroxide, the physical interaction with Ero1𝛼 likely
places the GPxs in a privileged position relative to PrxIV to
detoxify Ero1𝛼-derived H
2
O
2
.
Irrespective of the peroxide source, the catalytic mecha-
nism for the reductive regeneration of GPx7/8 remains con-
troversial. Despite the absence of a canonical CR, GPx7 and
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Table 1: Published peroxide and reducing substrates of ER-resident peroxidases.
Peroxide substrates Reducing substrates
PrxIV H2O2 [76] PDIs (ERp46, P5, PDI) [75, 83]
GPx7 H2O2 [88]phospholipid hydroperoxide [86]
PDIs (PDI, ERp46, ERp57, ERp72, P5)
[86, 88, 89], GRP78/BiP [90], GSH [86], XRN2 [93]
GPx8 H2O2 [88] PDIs (PDI, ERp46, ERp57, ERp72, P5) [88]
8 harbor an additional cysteine in a conserved Pro-Cys86/108-
Asn-Gln-Phe motif [86]. Studies with GPx7 have highlighted
two possiblemechanisms of peroxidase reduction [86, 89, 90]
(Figure 4(a)). Of note, one of the possibilities features Cys86
as a noncanonical CR. However, since CP and Cys
86 are ∼11 A˚
apart in the crystal structure (Figure 4(b)), this implies a
major conformational change. Indeed upon H
2
O
2
addition,
the intrinsic fluorescence of Trp142, which, in reduced GPx7,
is particularly solvent-exposed and in close proximity to CP
(Figure 4(b)), readily resumes in the time scale of 2-3 sec after
initial decline [88, 89]. This likely indicates the translocation
of Trp142 away from the fluorescence-quenching CP sulfenic
acid. In this connection, we note the adjacent aromatic
side chain of Phe89, which is part of the conserved motif
surrounding Cys86 (see above), and speculate that stacking of
Phe89 and Trp142 upon CP oxidation could promote forma-
tion of the CP–Cys
86 disulfide (Figure 4(b)). Interestingly, in
addition to the Pro-Cys-Asn-Gln-Phe motif, the exposed Trp
residue is conserved throughout the GPx family [86].
If GPx7 (and likely GPx8) can oxidize reducing substrates
in the absence of Cys86/108, what could be the reason for its
conservation? We suggest that the function of CR-dependent
intramolecular disulfide-bond formation is to prevent the
accumulation of sulfenylated GPxs, which may display reac-
tivity towards nonnative thiol substrates. Rapid reaction
with Cys86 largely prevents the accumulation of the CP-
sulfenylated form of purified GPx7 in presence of H
2
O
2
[89].
It will be interesting to assay the oxidation state of GPx7 and 8
in living cells. At all events, evidence for a possible toxic gain-
of-function of sulfenylated GPxs came from experiments
with an engineered H
2
O
2
-sensing fluorescent protein [91].
This protein is a fusion of redox-sensitive GFP (roGFP2)
and Orp1, which is yeast GPx3. Mutation of CR in Orp1
accelerated disulfide-bond formation in roGFP2 in response
to H
2
O
2
in vitro. In living cells, however, the CR-mutant
sensor failed to respond to H
2
O
2
addition, which was due
to competing reactions with reducing substrates other than
roGFP2 including glutathione [91].
5. Reducing Substrates of ER-Resident GPxs
In analogy to PrxIV, oxidized GPx7 and 8 were demonstrated
to act as PDI peroxidases by using several different PDIs
as electron donors [88] (Table 1). The utility of disulfide
transfer onto PDIs shall be discussed in the next section.
Here, we will touch upon alternative reducing substrates,
which have been found to interact with GPx7 (Table 1). For
instance, although glutathione reduces sulfenylated GPx7 at
a far lower rate compared to PDI, it has been calculated
to potentially represent a competing substrate taking into
account its millimolar concentration in vivo [86]. However,
since the reaction of glutathione with oxidized PDI is very
fast [92], the physiological relevance of direct glutathione-
mediated reduction of GPx7 is questionable.
In contrast, disulfide transfer from GPx7 to the abundant
ER chaperone and UPR target GRP78/BiP—as evidenced
by cysteine-dependent coimmunoprecipitation from H
2
O
2
-
treated cells—appears to have critical influence on ER
physiology [90]. GRP78/BiP carrying the resulting Cys41–
Cys420 disulfide exhibits increased chaperone activity towards
misfolded clients, arguing for a role of GPx7 as oxidative
stress sensor and positive regulator of GRP78/BiP [90]. Con-
sistently, cells lacking active GPx7 were more susceptible to
H
2
O
2
and ER-stress-induced toxicity than wild-type control
cells [90]. Very much like PrxIV knockout cells (see above),
they also displayed increased staining with a H
2
O
2
-reactive
dye compared to wild-type [90].
Nontargeting siRNA-transfected GPx7 knockout cells
displayed harmfully elevated levels of siRNA compared
to transfected wild-type cells, indicating a potential link
between ER-resident GPx7 and the degradation machinery
of nontargeting cytoplasmic siRNA [93]. This link was pro-
posed to involve thiol-disulfide transfer between GPx7 and
the nuclear exoribonuclease XRN2, although this reaction
appears topologically prohibited [93]. Irrespective of this
paradox but consistent with a role of GPx7 in the processing
of small RNAs, nontargeting siRNA selectively inducedGPx7
expression in wild-type fibroblasts [93], a process mediated
by the nuclear protein nucleolin and its activity as transacti-
vator of the GPx7 promotor [94]. It is interesting to note that
the cytosolic membrane leaflet of the rough ER is emerging
as a central nucleation site of miRNA/siRNA processing in
plants and animals [95, 96], and the interplay between the
RNA silencing machinery and GPx7 (and possibly other ER-
resident peroxidases) deserves further attention.
Compared to GPx7, the enzymatic characterization of
GPx8 including the identification of its reducing substrates
is far less developed. However, since the structures of their
active sites are nearly superimposable (Figure 3), GPx7 and 8
are likely to share many of their catalytic properties.
6. The Two-Disulfides-out-of-One-O2 Concept
Oxidative protein folding relies on de novo disulfide gener-
ating enzymes and on oxidants, which accept the electrons
derived from thiol oxidation. While several such electron
transfer cascades exist in the mammalian ER, resulting in
a certain degree of redundancy, Ero1 oxidases (using O
2
as
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Figure 4: Suggested reaction mechanisms of GPx7. (a) Following peroxide-mediated oxidation of the active site Cys (C57), sulfenylated C57 is
either directly subjected to nucleophilic attack by a (deprotonated) Cys in the reducing substrate (PDIs/GRP78) or attacked by (deprotonated)
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oxidant) and PrxIV (using H
2
O
2
as oxidant) are evidently
the dominant disulfide sources [29, 36, 81].The fact that both
enzymes can oxidize PDIs [75, 78, 81, 83, 97, 98] has led to
the intriguing concept that the four oxidizing equivalents in
O
2
can be exploited by the consecutive activity of Ero1 and
PrxIV to generate two disulfides for oxidative protein folding
[79, 99] (Figure 5). Along the same lines, the PDI peroxidase
activity of GPx7 constitutes a pathway for the productive
use of Ero1𝛼-derived H
2
O
2
in the biosynthesis of disulfides
[88, 89].
Evidence for a contribution of ER-resident peroxidases to
oxidative protein folding is manifold. Mixed disulfide reac-
tion intermediates between peroxidase and PDI were isolated
from cells [75, 81, 89], and in the case of PrxIV, interactions
with the PDI family members ERp46 and P5 were also
reported [75, 83]. Interestingly, of the twoCys-X-X-Cys active
sites in PDI, PrxIV preferentially oxidizes the a󸀠 domain
active site andGPx7 the adomain active site [75, 89]. Since the
mixed-disulfide complexes were stabilized by a Cys-X-X-Ala
active site configuration in PDI [75], they must have resulted
from the reaction of reduced PDI with oxidized peroxidase
[100]. Accordingly, consumed peroxidase molecules can be
activated/recycled by PDIs. It is possible that the availability
of reduced PDIs actively adjusts the activation state of ER
peroxidases. Thus, peroxidases could be kept in an inactive
state unless new disulfides are needed, as indicated by the
accumulation of reduced PDIs. In a very related manner, the
intramolecular disulfides, which shut off Ero1𝛼, are feedback-
regulated by the availability of reduced PDI [101]. In contrast
to Ero1𝛼, however, the redox state of PrxIV appears to be
predominantly reduced in cells at steady state [83].
Peroxidase/PDI-catalyzed oxidative protein folding can
be reconstituted. Refolding of reduced RNase A, a process
requiring introduction of four disulfides, occurs in the
presence of PDI together with PrxIV or GPx7 [81, 89]. It
is important to note though that PrxIV-driven refolding
appears to depend on the addition of H
2
O
2
, whereas GPx7-
driven refolding readily works in presence of Ero1𝛼, which
generates H
2
O
2
by reducing ambient O
2
[81, 89]. This differ-
ence parallels the evidence discussed above for a preference
of GPx7 or 8 over PrxIV to detoxify Ero1𝛼-derived H
2
O
2
.
The role of PrxIV as a source of disulfide bonds is also
strongly supported by genetics. Ero1-deficient mouse embry-
onic fibroblasts are hypersensitive to the loss of PrxIV, which
causes hypooxidation of an ER-targeted thiol-disulfide sen-
sor, ER dilation, and decreased cell viability [81]. Somewhat
counterintuitively, compound loss of Ero1𝛼/𝛽 and PrxIV also
leads to oxidative phenotypes such as glutathione depletion
and cell senescence [82]. These phenotypes are attributed to
the failure to reduce H
2
O
2
from as yet unidentified origin,
which causes shortage of intracellular ascorbate (vitamin
C) associated with defects in collagen synthesis and scurvy
[82]. Last but not least, codepletion of PrxIV in hepatocytes
exacerbates the cytotoxic phenotype of Ero1𝛼/𝛽 depletion
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2
concept. O
2
(red)-mediated oxidation of Ero1𝛼 results in the generation of one disulfide bond
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2
O
2
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2
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2
to H
2
O with the introduction of a second disulfide bond
(red) into a PDI family member, thereby exploiting the oxidizing capacity of H
2
O
2
.
and further slows ER reoxidation after reductive challenge
[36].
Taken together, a role in oxidative protein folding is
particularly well documented for PrxIV but is also shared by
the ER-residentGPxs. Still, although appealing,we consider it
likely that the concept of peroxidase-dependent exploitation
of Ero1𝛼-derived H
2
O
2
(Figure 5) only applies to GPxs (see
above).
7. Organismal Roles of ER Peroxidases
For PrxIV and GPx7, in vivo studies have been performed in
different model organisms. One striking conclusion of these
studies is that whole-body loss-of-function of GPx7 in mice
shows a stronger organismal phenotype compared to PrxIV
deficiency. No in vivo characterization of the role of GPx8 has
been published so far.
Male mice lacking a functional X-chromosomal PRDX4
gene (PrxIV−/𝑦) display a mild phenotype, which mani-
fests predominantly by testicular atrophy accompanied by
increased DNA fragmentation and peroxidation of lipids and
proteins [69]. The number of sperms is markedly decreased
in the epididymis of PrxIV−/𝑦 mice, which, however, does
not affect their fertility [69]. These phenotypes are likely
attributed to loss of the testis-specific transmembrane iso-
form of PrxIV [65].
Similarly, in fruit flies a decrease in PrxIV expression
to 10–20% of wild-type levels is associated with increased
[H
2
O
2
] and lipid peroxidation in membrane preparations
from whole animals [102]. However, negative impact on
longevitywas only observed under oxidative stress conditions
induced by H
2
O
2
or paraquat treatment. Strikingly, 6–10
fold, global overexpression of PrxIV in flies, which shifted
its subcellular distribution from predominantly ER-resident
to cytosolic and secreted, resulted in dramatically shortened
lifespan under nonstress conditions and increased apoptosis
in thoracic muscle and fat body tissue [102]. Since this
proapoptotic phenotype upon PrxIV overexpression was not
reproducible in cultured fly cells, noncell autonomous and/or
fly-specific in vivo effects of secreted PrxIV need further
consideration.
In contrast to this, overexpression of PrxIV in mice
has beneficial effects in the context of metabolic diseases.
For instance, elevated levels of PrxIV in apolipoprotein E
negative mice, which were fed a high cholesterol diet, have
antiatherogenic effects with less oxidative stress, a decrease
in apoptosis, and suppressed T-lymphocyte infiltration [103].
In addition, cytoprotective effects of overexpressed PrxIV
were evident in nongenetic mouse models of both type 1
and type 2 diabetes mellitus (T1DM and T2DM) [104, 105].
Specifically, autoimmune-induced apoptosis of pancreatic 𝛽-
cells (in T1DM) and fatty liver phenotypes and peripheral
insulin resistance (in T2DM) were diminished upon PrxIV
overexpression. It is possible that more efficient clearance
of inflammatory ROS is the underlying reason for the
ameliorated phenotypes of these mice [104, 105]. However,
one has to bear in mind that overexpression of PrxIV above
a certain threshold exceeds ERp44-mediated ESP retrieval
[67] and therefore may result in abnormally high levels of
secreted peroxidase. Overexpression studies therefore need
careful evaluation, before implications on normal physiology
can be conclusively deduced.
Interestingly, endogenous PrxIV is dramatically upregu-
lated during terminal B-cell differentiation [106], a process
accompanied by increased ROS levels but not by discernible
hyperoxidation of the ER lumen [107, 108]. PrxIV knockout
splenocytes, however, develop normally and do not show a
defect in antibody secretion, arguing for redundancy among
different oxidant control mechanisms [106].
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In contrast to the relatively mild PrxIV knockout pheno-
type [69], quite dramatic changes including a shortened lifes-
pan were documented for GPx7−/− compared to control mice
[90]. Besides induction of UPR hallmarks in different organs,
these mice exhibited oxidative DNA damage and apoptosis
predominantly in the kidney. Furthermore, multiple organ
dysfunctions including glomerulonephritis, spleno- and car-
diomegaly, fatty liver, andmultiplemalignant neoplasmswere
diagnosed [90]. Carcinogenesis and premature death were
concluded to reflect systemic oxidative stress [90].
Along this line, Peng and coworkers proposed a tumor-
suppressive role forGPx7 in oesophageal epithelial cells [109].
Progression from healthy tissue to premalignant Barrett’s
oesophagus (BO) and further to malignant oesophageal ade-
nocarcinoma (OAC) is associated with gastro-oesophageal
reflux, leading to ROS accumulation and increased oxida-
tive DNA damage. BO/OAC neoplastic transformation is
accompanied by decreased expression of GPx7 [110]. The
diminished levels of GPx7 in BO and OAC tissues are due
to DNA-hypermethylation within the respective promoter
region. Bile acid-mediated intracellular and extracellular
ROS accumulation in oesophageal epithelial cell culture
was also responsive to overexpression or downregulation of
GPx7 [111]. Furthermore, reconstitution of GPx7 expression
suppressed growth and promoted cellular senescence in both
in vitro and in vivoOACmodels [109].Therefore, inactivation
of GPx7 is a crucial step in BO/OAC formation. Despite
these conclusive links between oxidative injury and GPx7
expression in vivo, it is important to emphasize that the actual
source of peroxide that causes ROS accumulation in absence
of GPx7 remains to be identified. A possible involvement of
Ero1𝛼 [112] remains to be experimentally verified.
8. Conclusions and Perspectives
The reaction cycle of a peroxidase is split into an oxidizing
part, which uses a source of hydroperoxide, and a reductive
part, which uses a dithiol substrate. As such, available data
highlight a twofold function of ER-resident peroxidases; on
one hand, they can reduce and spatially restrict local H
2
O
2
or lipid hydroperoxides and on the other hand, they are net
producers of disulfide bonds.
The model, which has probably generated the highest
resonance, holds that ER peroxidases eliminate the obliga-
tory and potentially harmful side product of Ero1-catalyzed
disulfide-bond formation, H
2
O
2
, by exploiting its oxidizing
power to generate a second disulfide in PDI for oxidative
protein folding (Figure 5). The fact that all ER peroxidases—
PrxIV, GPx7, and GPx8—can catalyze steps of this pathway
in vitro [75, 81, 88, 89] has led to the understanding that
they basically perform the same function [65]. But do ER
peroxidases really all do the same? Are their functions
redundant? We believe that this is clearly not the case. For
instance, the prominent phenotype of the GPx7−/− mouse
strongly suggests that neither PrxIV nor GPx8 can broadly
substitute for the loss of GPx7 [90]. This could be due to
the fact that GPx7 uses unique reducing substrates (other
than PDI family members) or metabolizes phospholipid
hydroperoxides in the ER-facing membrane leaflet in vivo.
Alternatively, tissue-specific expression levels might prohibit
functional compensation between ER peroxidases. These
questions are exciting subjects for future research. Clearly,
it will also be interesting to learn about the phenotypes of
GPx8−/− and GPx7/8 double knockout animals. Whether or
not other human GPx isoforms like for example, the ubiq-
uitously secreted GPx3 [21] have an additional intracellular
function in the ER is another open question.
Differences between ER peroxidases also manifest in
terms of the source of hydroperoxide. There is clear proof
for PrxIV reacting with Ero1-independent H
2
O
2
[81, 82], and
unpublished data from our laboratory has demonstrated that
this peroxidase does not react with Ero1𝛼-derived H
2
O
2
in
cells under steady-state conditions. In this respect, one of
the most urgent questions is which is the H
2
O
2
source that
drives PrxIV-dependent oxidative protein folding [36, 81, 82].
Identification of this source will likely provide major new
insights into the diffusion pathways of this metabolite.
Another area for future investigation concerns potential
signaling roles of H
2
O
2
in the ER lumen and beyond. For
instance, the interplay of ER-resident NOX family members
and peroxidases is largely unexplored. Likewise, it is currently
unclear whether or not the known proapoptotic role of Ero1𝛼
during ER stress [113–115] is mediated by diffusion of Ero1𝛼-
derived H
2
O
2
into the cytoplasm, as is suggested [7]. It is
foreseeable that aquaporins will be found to play a central
function in these processes at the ER membrane [8]. As
every discovery arouses further interest and curiosity, we are
expecting new insights and again new questions to come.
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